Celldex Therapeutics Current Ratio 2010-2022 | CLDX
Celldex Therapeutics current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Celldex Therapeutics Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-09-30 |
$0.34B |
$0.02B |
20.54 |
2022-06-30 |
$0.37B |
$0.03B |
12.29 |
2022-03-31 |
$0.39B |
$0.02B |
26.83 |
2021-12-31 |
$0.41B |
$0.02B |
24.86 |
2021-09-30 |
$0.43B |
$0.01B |
30.09 |
2021-06-30 |
$0.17B |
$0.01B |
11.57 |
2021-03-31 |
$0.18B |
$0.02B |
10.69 |
2020-12-31 |
$0.20B |
$0.01B |
13.93 |
2020-09-30 |
$0.20B |
$0.01B |
16.63 |
2020-06-30 |
$0.21B |
$0.01B |
19.28 |
2020-03-31 |
$0.06B |
$0.01B |
5.12 |
2019-12-31 |
$0.07B |
$0.01B |
5.73 |
2019-09-30 |
$0.08B |
$0.01B |
6.32 |
2019-06-30 |
$0.08B |
$0.01B |
7.33 |
2019-03-31 |
$0.09B |
$0.01B |
7.41 |
2018-12-31 |
$0.10B |
$0.01B |
7.86 |
2018-09-30 |
$0.11B |
$0.02B |
6.59 |
2018-06-30 |
$0.12B |
$0.02B |
6.02 |
2018-03-31 |
$0.13B |
$0.02B |
5.45 |
2017-12-31 |
$0.15B |
$0.03B |
5.22 |
2017-09-30 |
$0.15B |
$0.03B |
5.91 |
2017-06-30 |
$0.16B |
$0.03B |
5.56 |
2017-03-31 |
$0.17B |
$0.03B |
6.42 |
2016-12-31 |
$0.20B |
$0.04B |
5.55 |
2016-09-30 |
$0.21B |
$0.02B |
11.26 |
2016-06-30 |
$0.23B |
$0.02B |
11.44 |
2016-03-31 |
$0.26B |
$0.03B |
10.31 |
2015-12-31 |
$0.30B |
$0.03B |
9.75 |
2015-09-30 |
$0.31B |
$0.02B |
13.09 |
2015-06-30 |
$0.34B |
$0.03B |
12.72 |
2015-03-31 |
$0.36B |
$0.02B |
17.22 |
2014-12-31 |
$0.21B |
$0.02B |
8.37 |
2014-09-30 |
$0.23B |
$0.02B |
10.63 |
2014-06-30 |
$0.26B |
$0.02B |
12.06 |
2014-03-31 |
$0.28B |
$0.02B |
14.19 |
2013-12-31 |
$0.31B |
$0.02B |
15.00 |
2013-09-30 |
$0.14B |
$0.02B |
8.33 |
2013-06-30 |
$0.16B |
$0.01B |
12.51 |
2013-03-31 |
$0.18B |
$0.02B |
10.06 |
2012-12-31 |
$0.09B |
$0.02B |
4.81 |
2012-09-30 |
$0.08B |
$0.02B |
5.21 |
2012-06-30 |
$0.08B |
$0.01B |
6.39 |
2012-03-31 |
$0.09B |
$0.01B |
7.51 |
2011-12-31 |
$0.06B |
$0.01B |
3.83 |
2011-09-30 |
$0.06B |
$0.01B |
5.97 |
2011-06-30 |
$0.07B |
$0.01B |
7.04 |
2011-03-31 |
$0.05B |
$0.01B |
5.18 |
2010-12-31 |
$0.06B |
$0.02B |
3.12 |
2010-09-30 |
$0.06B |
$0.02B |
2.54 |
2010-06-30 |
$0.07B |
$0.02B |
2.88 |
2010-03-31 |
$0.08B |
$0.03B |
3.15 |
2009-12-31 |
$0.08B |
$0.01B |
5.83 |
2009-09-30 |
$0.03B |
$0.01B |
1.99 |
2009-06-30 |
$0.03B |
$0.01B |
2.61 |
2009-03-31 |
$0.04B |
$0.01B |
2.98 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$2.171B |
$0.005B |
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
|